search
Back to results

Comparison of A Single Dose Combination of Methadone and Morphine With Morphine Alone for Treating Post-operative Pain

Primary Purpose

Pain

Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Methadone
methadone and morphine
Sponsored by
Memorial Sloan Kettering Cancer Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pain focused on measuring Pain, Analgesics, Retroperitoneal lymph node dissection

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Retroperitoneal lymph node dissection Planned post-operative analgesia with PCA at 1 mg continuous infusion and 1 mg every 10 minutes 18 years of age or older English-speaking Give informed consent to participate in this study Exclusion Criteria: Known hypersensitivity to methadone or morphine Patients with past or present history of substance abuse Patients with a history of methadone treatment Patients with a history of chronic pain requiring daily analgesic use for more than 3 months Patients treated with opioids within one month from the scheduled surgery Creatinine clearance less than 50 mg/kg (using Cockcroft-Gault Equation). Neurologic or psychiatric disease sufficient, in the doctor's opinion, to compromise data collection

Sites / Locations

  • Memorial Sloan Kettering Cancer Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

1

2

Arm Description

methadone

methadone and morphine

Outcomes

Primary Outcome Measures

The Primary Goal of This Study is to Compare the Analgesic Effects of a Combination of Morphine and Methadone With Morphine Alone to Determine Synergistic Activity of mu Opioid Analgesics in Patients With Post-operative Pain.

Secondary Outcome Measures

To Determine if There Are Any Side Effects From the Combination of Morphine and Methadone When Given Together.

Full Information

First Posted
August 31, 2005
Last Updated
March 14, 2019
Sponsor
Memorial Sloan Kettering Cancer Center
search

1. Study Identification

Unique Protocol Identification Number
NCT00142519
Brief Title
Comparison of A Single Dose Combination of Methadone and Morphine With Morphine Alone for Treating Post-operative Pain
Official Title
Translational Studies in Analgesic Pharmacology: Analgesic Synergy in Clinical Pain. A Phase 2 Study Comparing a Single Dose of a 1:1 Combination of Methadone and Morphine With Morphine Alone in Patients With Post-operative Pain.
Study Type
Interventional

2. Study Status

Record Verification Date
August 2018
Overall Recruitment Status
Completed
Study Start Date
March 2005 (Actual)
Primary Completion Date
July 2018 (Actual)
Study Completion Date
July 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Memorial Sloan Kettering Cancer Center

4. Oversight

5. Study Description

Brief Summary
This is a randomized Phase II study testing the effectiveness of the combination of morphine and methadone versus morphine alone in relieving pain. A second goal is to further evaluate any side effects of the combination of morphine and methadone.
Detailed Description
Rationale: Experimental data demonstrates a profound analgesic synergy between morphine and methadone when co-administered systemically in mice. If this type of synergy can be demonstrated in clinical pain, it will be a relatively unique example of translating concepts of fundamental aspects of opioid actions seen in the laboratory to the clinical area, and provide a basis for offering new and scientifically- based analgesic regimens. This may provide better pain relief with less opioid related side effects in clinical practice. Purpose: This is a randomized, double blind, parallel arm Phase II study comparing a single dose of 1:1 combination of methadone and morphine with morphine alone in patients with post-operative pain. The primary objective of this randomized, double blind, parallel arm Phase II study is to compare the analgesic effects of a combination of morphine and methadone with morphine alone to determine synergistic activity of mu opioid analgesics in patients with post-operative pain. A second goal is to further evaluate any side effects of the combination of morphine and methadone.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pain
Keywords
Pain, Analgesics, Retroperitoneal lymph node dissection

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
50 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Active Comparator
Arm Description
methadone
Arm Title
2
Arm Type
Experimental
Arm Description
methadone and morphine
Intervention Type
Drug
Intervention Name(s)
Methadone
Intervention Description
Upon the 1st request for analgesic medication morphine 2 mg, upon the 2nd request for analgesic medication morphine 2 mg
Intervention Type
Drug
Intervention Name(s)
methadone and morphine
Intervention Description
Upon the 1st request for analgesic medication morphine 2 mg, upon the 2nd request for analgesic medication morphine 1 mg and methadone 1 mg
Primary Outcome Measure Information:
Title
The Primary Goal of This Study is to Compare the Analgesic Effects of a Combination of Morphine and Methadone With Morphine Alone to Determine Synergistic Activity of mu Opioid Analgesics in Patients With Post-operative Pain.
Time Frame
Time to the third request for the pain medication
Secondary Outcome Measure Information:
Title
To Determine if There Are Any Side Effects From the Combination of Morphine and Methadone When Given Together.
Time Frame
assessed every 10 minutes

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Retroperitoneal lymph node dissection Planned post-operative analgesia with PCA at 1 mg continuous infusion and 1 mg every 10 minutes 18 years of age or older English-speaking Give informed consent to participate in this study Exclusion Criteria: Known hypersensitivity to methadone or morphine Patients with past or present history of substance abuse Patients with a history of methadone treatment Patients with a history of chronic pain requiring daily analgesic use for more than 3 months Patients treated with opioids within one month from the scheduled surgery Creatinine clearance less than 50 mg/kg (using Cockcroft-Gault Equation). Neurologic or psychiatric disease sufficient, in the doctor's opinion, to compromise data collection
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Natalia Moryl, MD
Organizational Affiliation
Memorial Sloan Kettering Cancer Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Memorial Sloan Kettering Cancer Center
City
New York
State/Province
New York
ZIP/Postal Code
10065
Country
United States

12. IPD Sharing Statement

Links:
URL
http://mskcc.org
Description
Memorial Sloan Kettering Cancer Center

Learn more about this trial

Comparison of A Single Dose Combination of Methadone and Morphine With Morphine Alone for Treating Post-operative Pain

We'll reach out to this number within 24 hrs